Ascending aorta dilatation is associated to hard cardiovascular events, follow-up from multicentric ARGO-Perspective

Lorenzo Airale1, Francesco Borrelli1, Alessio Arrivi2

  • 1Department of Medical Sciences, Hypertension Center-University of Torino-AOU Città della Salute e della Scienza di Torino, Torino, Italy.

Insights

Aortic root dilatation is linked to a higher risk of major adverse cardiovascular events in hypertensive patients. This finding highlights aortic dilatation as a significant predictor of cardiovascular outcomes, even after accounting for other risk factors.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Vascular Medicine

Background:

  • Aortic root dilatation is a potential hypertension-mediated organ damage (HMOD).
  • Previous studies on aortic root dilatation as HMOD are heterogeneous, lacking clarity on its role.
  • Essential hypertension poses significant cardiovascular risks, necessitating identification of all HMODs.

Purpose of the Study:

  • To investigate the association between aortic root dilatation (AAD) and major adverse cardiovascular events (MACE).
  • To determine if AAD is an independent predictor of MACE in patients with essential hypertension.
  • To clarify the role of AAD as a potential HMOD.

Main Methods:

  • A cohort of 445 hypertensive patients was recruited from six Italian hospitals (ARGO-SIIA study).
  • Patients were followed for a median of 60 months, with data collected via telephone and hospital records.
  • Aortic dilatation was defined using sex-specific thresholds (41 mm for males, 36 mm for females).

Main Results:

  • AAD was significantly associated with an increased occurrence of MACE (HR=4.07, p<0.001).
  • This association remained significant after adjusting for age, sex, and body surface area (HR=2.91, p=0.020).
  • AAD was an independent predictor of MACE, even after correction for established HMODs like left atrial enlargement and left ventricular hypertrophy (HR=2.43, p=0.045).

Conclusions:

  • Ascending aorta dilatation is associated with a substantially increased risk of MACE in hypertensive individuals.
  • AAD should be considered a significant predictor of cardiovascular events in essential hypertension.
  • Identifying and managing aortic root dilatation may be crucial for preventing cardiovascular complications in hypertensive patients.

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
33
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
11
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
26
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
16
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
19
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
12